Search Results

You are looking at 91 - 100 of 1,651 items for :

  • "chemotherapy" x
Clear All
Full access

David C. Dale, Gordon C. McCarter, Jeffrey Crawford and Gary H. Lyman

results of 20 years of follow-up . N Engl J Med 1995 ; 332 : 901 – 906 . 2 Wood WC Budman DR Korzun AH . Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma . N Engl J Med 1994 ; 330 : 1253

Full access

Richard I. Fisher

/doxorubicin/vincristine/prednisone] vs mAb/bendamustine), and now, chemotherapy-free treatment with targeted agents. Chemotherapy-free treatment can be considered as a first-line treatment option for FL, but only in selected patients, Dr. Fisher emphasized. “I would argue that rituximab

Full access

Jacob P. Laubach, Constantine S. Mitsiades, Anuj Mahindra, Robert L. Schlossman, Teru Hideshima, Dharminder Chauhan, Nicole A. Carreau, Irene M. Ghobrial, Noopur Raje, Nikhil C. Munshi, Kenneth C. Anderson and Paul G. Richardson

Anderson H Scarffe JH Ranson M . VAD chemotherapy as remission induction for multiple myeloma . Br J Cancer 1995 ; 71 : 326 – 330 . 19 Alexanian R Barlogie B Dixon D . High dose glucocorticoid treatment of resistant myeloma . Ann Intern Med

Full access

Siu-Fun Wong, Mark Bounthavong, Cham P. Nguyen and Timothy Chen

Background Historically, patients with cancer primarily receive intravenous anticancer chemotherapy and are monitored for efficacy, side effects, and adherence in the supervised setting of an infusion clinic. Approximately 25% of 400 novel

Full access

Athanassios Argiris

Surg 1987 ; 10 : 19 – 30 . 3 Taylor SGT . Why has so much chemotherapy done so little in head and neck cancer? J Clin Oncol 1987 ; 5 : 1 – 3 . 4 Rosenthal DI Pistenmaa DA Glatstein E . A review of neoadjuvant chemotherapy

Full access

Ciara C. O'Sullivan, Holly K. Van Houten, Lindsey R. Sangaralingham, Alexis D. Leal, Shivani Shinde, Hongfang Liu, David Ettinger, Charles L. Loprinzi and Kathryn J. Ruddy

Chemotherapy-induced nausea and vomiting (CINV) is common during cancer treatment due to a complex multifactorial process involving several different pathways and transmitters. Highly emetogenic chemotherapy (HEC) regimens are associated with >90

Full access

Crystal Weaver, Mark Varvares, Elaine Ottenlips, Kara Christopher and Andrew Dwiggins

anxiety levels of oncology patients during chemotherapy treatments. Purpose: To determine if listening to live music performed by community musicians decreases oncology patient anxiety levels during chemotherapy treatments in an outpatient infusion

Full access

Gary L. Gallia, Steven Brem and Henry Brem

Schoenfeld D . Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

Full access

Nikhil Khandelwal, Ian Duncan, Tamim Ahmed, Elan Rubinstein and Cheryl Pegus

Several oral chemotherapies and biologic therapies have been introduced in the past decade for use alone and combined with intravenous chemotherapy. The role of oral chemotherapy agents in cancer management will likely increase. 1 Oral

Full access

Megan Gershon, Justine Pena, Chamnjot Bains, Sarah Salas, Tresa McGranahan and Seema Nagpal

Background: The development of oral chemotherapies (OC) have transformed cancer care for millions of patients. Most patients with brain tumors have temozolomide (TMZ) delivered to their home. While this has improved the patient experience, it